Institutional Ownership Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). We have compiled data on the 75 institutions that hold shares in the stock, with a total of 114 Million shares, which have been reported (via 13F filing form) to have a value of $32 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Wealth Enhancement Advisory Services, LLC
|
Jul 10, 2025 Q2 2025 |
10,816
shares
|
$3,028
0.0% of portfolio
|
Q2 2025
Reduced 59.67%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
10,113
shares
|
$2,831
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Ifg Advisory, LLC
|
May 08, 2025 Q1 2025 |
10,000
shares
|
$2,800
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Global Retirement Partners, LLC
|
Jan 31, 2025 Q4 2024 |
6,000
shares
|
$1,680
0.0% of portfolio
|
Q1 2023
New holding
|
|
|
Lindbrook Capital, LLC
|
May 05, 2025 Q1 2025 |
4,610
shares
|
$1,290
0.0% of portfolio
|
Q4 2024
Reduced 4.89%
|
|
|
Cibc Private Wealth Group, LLC
|
May 14, 2025 Q1 2025 |
3,023
shares
|
$846
0.0% of portfolio
|
Q2 2024
Reduced 96.06%
|
|
|
Banque Transatlantique Sa
Paris, I0 |
May 15, 2025 Q1 2025 |
1,824
shares
|
$510
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Sandy Spring Bank
|
May 12, 2025 Q1 2025 |
1,050
shares
|
$294
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Plante Moran Financial Advisors, LLC
|
May 08, 2025 Q1 2025 |
925
shares
|
$259
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Raiffeisen Bank International Ag
Vienna, C4 |
May 09, 2025 Q1 2025 |
907
shares
|
$253
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Garde Capital, Inc.
Seattle, WA |
Jul 03, 2025 Q2 2025 |
750
shares
|
$210
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Bryn Mawr Trust CO
Bryn Mawr, PA |
May 08, 2025 Q1 2025 |
604
shares
|
$169
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Carmichael Hill & Associates, Inc.
|
Oct 29, 2024 Q3 2024 |
525
shares
|
$147
0.0% of portfolio
|
Q1 2022
Added 50.0%
|
|
|
High Mark Wealth Management LLC
|
Jul 21, 2025 Q2 2025 |
287
shares
|
$80
0.0% of portfolio
|
Q3 2023
Reduced 77.38%
|
|
|
Parallel Advisors, LLC
|
Jul 07, 2025 Q2 2025 |
250
shares
|
$70
0.0% of portfolio
|
Q4 2024
Reduced 96.52%
|
|
|
Transce3nd, LLC
Kyle, TX |
May 02, 2025 Q1 2025 |
175
shares
|
$49
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Group One Trading, L.P.
Chicago, IL |
May 14, 2025 Q1 2025 |
147
shares
|
$41
0.0% of portfolio
|
Q1 2025
Reduced 99.28%
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
121
shares
|
$33
0.0% of portfolio
|
Q3 2018
Reduced 99.1%
|
|
|
Investors Research Corp
|
Jul 07, 2025 Q2 2025 |
100
shares
|
$28
0.0% of portfolio
|
Q3 2023
Reduced 50.0%
|
|
|
Td Waterhouse Canada Inc.
Toronto, A6 |
May 09, 2025 Q1 2025 |
14
shares
|
$3
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
May 01, 2025 Q1 2025 |
10
shares
|
$2
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|